H ao Hong is a Chinese-American billionaire who is the chairman of Asymchem Laboratories, a leading Chinese contract development and manufacturing organization (CDMO) for the pharmaceutical industry. A chemist with a PhD, he has built his fortune by providing essential outsourced services to major global drugmakers.

Asymchem specializes in the development and manufacturing of active pharmaceutical ingredients (APIs) and other key components for new drugs. The company is a crucial partner for many large pharmaceutical companies, helping them to scale up the production of their drugs for clinical trials and commercial launch. The company is publicly traded on the Shenzhen Stock Exchange, and its success in serving the global pharma industry is the source of Hong's considerable fortune.